|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C12N 15/85 | (2006.01) |
| C12N 9/22 | (2006.01) |
| (11) | Number of the document | 3080279 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14790457.7 |
| Date of filing the European patent application | 2014-10-15 | |
| (97) | Date of publication of the European application | 2016-10-19 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-26 |
| (46) | Date of publication of the claims translation | 2018-10-25 |
| (86) | Number | PCT/US2014/060788 |
| Date | 2014-10-15 |
| (87) | Number | WO 2015/088643 |
| Date | 2015-06-18 |
| (30) | Number | Date | Country code |
| 201361914768 P | 2013-12-11 | US | |
| 201462017416 P | 2014-06-26 | US | |
| 201462029261 P | 2014-07-25 | US | |
| 201462052906 P | 2014-09-19 | US | |
| 201462059527 P | 2014-10-03 | US |
| (72) |
FRENDEWEY, David, US
AUERBACH, Wojtek, US
LAI, Ka-Man Venus, US
VALENZUELA, David M., US
YANCOPOULOS, George D., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Būdai ir kompozicijos, skirti genomo tikslinei modifikacijai |
| METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME |
| Payment date | Validity (years) | Amount | |
| 2022-09-20 | 9 | 208.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2023-08-03 |